Patents by Inventor Eva Roedel

Eva Roedel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Multicomponent crystalline system comprising nilotinib and selected co-crystal formers
    Patent number: 9567317
    Abstract: The present invention relates to crystalline materials comprising nilotinib and a carboxylic acid, carboxylic acid ester, carboxylic acid amide or sulfonic acid as a co-crystal former, and to pharmaceutical compositions comprising said materials. The invention also relates to processes for preparing said crystalline materials and to methods of using said crystalline materials to treat a disease condition in which tyrosine kinase inhibition is beneficial.
    Type: Grant
    Filed: October 16, 2013
    Date of Patent: February 14, 2017
    Assignee: BASF SE
    Inventors: Tiziana Chiodo, Andreas Hafner, Tobias Hintermann, Beate Salvador, Martin Szelagiewicz, Fritz Blatter, Eva Roedel, Marcus Vossen
  • Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof
    Patent number: 9290452
    Abstract: The present invention refers to a multicomponent crystalline system (co-crystal) comprising a compound of formula (1) (4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; INN: Deferasirox) formula (1) and a compound of formula (2) (Isonicotinamide; pyridine-4-carboxamide) formula (2), as well as to a process for obtaining the same.
    Type: Grant
    Filed: August 5, 2013
    Date of Patent: March 22, 2016
    Assignee: BASF SE
    Inventors: Andreas Hafner, Fritz Blatter, Eva Roedel, Martin Szelagiewicz, Tiziana Chiodo, Tobias Hintermann, Beate Salvador, Marcus Vossen
  • MULTICOMPONENT CRYSTALLINE SYSTEM COMPRISING NILOTINIB AND SELECTED CO-CRYSTAL FORMERS
    Publication number: 20150246901
    Abstract: The present invention relates to crystalline materials comprising nilotinib and a carboxylic acid, carboxylic acid ester, carboxylic acid amide or sulfonic acid as a co-crystal former, and to pharmaceutical compositions comprising said materials. The invention also relates to processes for preparing said crystalline materials and to methods of using said crystalline materials to treat a disease condition in which tyrosine kinase inhibition is beneficial.
    Type: Application
    Filed: October 16, 2013
    Publication date: September 3, 2015
    Inventors: Tiziana Chiodo, Andreas Hafner, Tobias Hintermann, Beate Salvador, Martin Szelagiewicz, Fritz Blatter, Eva Roedel, Marcus Vossen
  • MULTICOMPONENT CRYSTALLINE SYSTEM COMPRISING DEFERASIROX AND ISONICOTINAMIDE AND A PROCESS FOR THE PREPARATION THEREOF
    Publication number: 20150175544
    Abstract: The present invention refers to a multicomponent crystalline system (co-crystal) comprising a compound of formula (1) (4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; INN: Deferasirox) formula (1) and a compound of formula (2) (Isonicotinamide; pyridine-4-carboxamide) formula (2), as well as to a process for obtaining the same.
    Type: Application
    Filed: August 5, 2013
    Publication date: June 25, 2015
    Applicant: BASF SE
    Inventors: Andreas Hafner, Fritz Blatter, Eva Roedel, Martin Szelagiewicz, Tiziana Chiodo, Tobias Hintermann, Beate Salvador, Marcus Vossen
  • MULTICOMPONENT CRYSTALLINE SYSTEM OF VORICONAZOLE WITH FUMARIC ACID
    Publication number: 20150087657
    Abstract: A novel solid form of Voriconazole comprises the active ingredient (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol and fumaric acid. The solid composition comprising the two components shows improved properties such as water solubility, crystallization behavior and stability.
    Type: Application
    Filed: December 3, 2012
    Publication date: March 26, 2015
    Applicant: BASF SE
    Inventors: Andreas Hafner, Tobias Hintermann, Fritz Blatter, Eva Roedel